BioMarin Pharmaceutical Inc. Profile Avatar - Palmy Investing

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysacc…
Biotechnology
US, San Rafael [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of BioMarin Pharmaceutical Inc.

Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
- -% Yield
0.00% Payout Ratio
End of BMRN's Analysis
CIK: 1048477 CUSIP: 09061G101 ISIN: US09061G1013 LEI: - UEI: -
Secondary Listings